AnalystsStan BerenshteynStan Berenshteyn's Stock Forecasts
AnalystsStan Berenshteyn
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#4793 out of 5067 analysts
Average Return
-3.8%
Win Rate
62%24 out of 39
Risk vs Reward
Poor
Good
Stan Berenshteyn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Accolade IncACCD | +53.41% | $13.80 | $6.43 | 2022-04-11 - 2022-05-02 | Strong Sell |
Omnicell IncOMCL | +51.58% | $62.87 | $30.44 | 2023-07-20 - 2023-11-03 | Strong Sell |
Healthequity IncHQY | +45.46% | $69.33 | $100.85 | 2023-12-06 - 2024-12-05 | Strong Buy |
Doximity IncDOCS | +35.25% | $26.47 | $35.80 | 2022-10-31 - 2023-05-01 | Strong Buy |
Omnicell IncOMCL | +33.22% | $45.58 | $30.44 | 2023-09-26 - 2023-11-03 | Strong Sell |
Stan Berenshteyn Analyst Color
Get additional color on Stan Berenshteyn's coverage of popular stocks
Stan Berenshteyn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Veeva Systems IncVEEV | 8 | Strong Buy | $341.00 | +16.49% | Maintains | 2 months ago |
Health Catalyst IncHCAT | 6 | Strong Buy | $6.00 | +94.17% | Maintains | 2 months ago |
Doximity IncDOCS | 12 | Hold | $65.00 | -3.46% | Maintains | 2 months ago |
American Well CorpAMWL | 4 | Strong Buy | $12.00 | +111.27% | Maintains | 2 months ago |
Omnicell IncOMCL | 17 | Strong Buy | $40.00 | +32.01% | Maintains | 3 months ago |
Teladoc Health IncTDOC | 3 | Hold | $8.00 | -11.31% | Maintains | 5 months ago |
Goodrx Holdings IncGDRX | 8 | Strong Buy | $7.00 | +79.49% | Maintains | 6 months ago |
Healthequity IncHQY | 9 | Strong Buy | $125.00 | +37.30% | Maintains | 8 months ago |
Accolade IncACCD | 10 | Hold | $6.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.